期刊文献+

无创正压机械通气治疗肾移植术后巨细胞病毒肺炎所致急性呼吸窘迫综合征 被引量:1

Noninvasive positive pressure ventilation for patients with acute respiratory distress syndrome as a result of CMV pneumonia after renal transplantation
原文传递
导出
摘要 目的探讨肾移植术后巨细胞病毒(CMV)肺炎合并急性呼吸窘迫综合征(ARDS)无创正压机械通气治疗效果。方法肾移植术后CMV肺炎合并ARDS患者10例。早期应用无创正压机械通气治疗及抗病毒、调整免疫抑制剂、加强营养支持的综合治疗。比较分析患者通气治疗前后动脉血气、生命指标及移植肾功能变化。结果10例患者中治愈7例。1例脱机时发生张力性气胸及广泛皮下气肿死亡;另2例治疗中病情加重改有创机械通气,治疗5、18d无效死亡。7例治愈患者上机前与上机后、脱机前的动脉血气分析血氧分压、血氧饱和度、血二氧化碳分压比较差异有统计学意义(P〈0.05);治疗前后患者血肌酐(平均156.25对101.85/μmol/L)、血尿素氮(平均11.93对6.55mmol/L)比较差异有统计学意义(P〈0.05)。结论早期应用无创正压机械通气辅以抗病毒为主的综合治疗,是提高重症CMV肺炎治愈率的重要措施。 Objective To discuss the clinical application of noninvasive positive pressure ventilation for patients with acute respiratory distress syndrome (ARDS) as a result of cytomegalovirus (CMV) interstitial pneumonia after renal transplantation. Methods There were 371 renal transplantation from March 2003 to October 2006, 27 patients were diagnosed as CMV pneumonia postoperation. Ten patients were treated with noninvasive positive pressure ventilation within the 11 patients who aggravated to ARDS. The clinical data of before and after mechanical ventilation were reviewed. Results Among patients received noninvasive positive pressure ventilation, 1 died of complication. Seven patients were cured by noninvasive positive pressure ventilation. Significant difference of the physiological index presented between the 7 patients cured with noninvasive positive pressure ventilation before and after the use of ventilation(P〈0.05), and significant difference of the renal function also existed(P〈0.05). Conclusion The major value of noninvasive positive pressure ventilation is to correct the hypoxemia.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2008年第9期628-630,共3页 Chinese Journal of Urology
关键词 巨细胞病毒 肾移植 急性呼吸窘迫综合征 无创正压机械通气 Cytomegalovirus Kidney transplantation Acute respiratory distress syndrome Noninvasive positive pressure ventilation
  • 相关文献

参考文献7

  • 1中华医学会呼吸病学分会.急性肺损伤/急性呼吸窘迫综合征的诊断标准(草案)[J].中华结核和呼吸杂志,2000,23(4):203-203.
  • 2Piiparinen H, Hockerstedt K, Gronhagen-Riska C, et al. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65 antigenemia assay in the determination of viral loads from peripheral blood of or gan transplant patients. J Clin Virol,2004,30 : 258-266.
  • 3Dickenmann MJ, Kabulbayev K, Steiger J, et al. Ganciclovir prophylaxis to prevent CMV disease in kidney recipients undergoing anti-lymphocyte globulin treatment for acute rejection. Clin Microbiol Infect,2004,10:337-339.
  • 4Boeckh M, Leisenring W, Riddell SR, et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T2 cell immunity. Blood,2003,101:407-414.
  • 5Metselaar HJ, Weimar W. Cytomegalovirus infection and renal transplantation. J Antimicrob Chemother, 1998,47 : 23-37.
  • 6曾文彤,叶青,罗光华,董选,何小舟.动态检测血浆CMV DNA载量在预测肾移植术后并发巨细胞病毒肺炎中的意义[J].中华泌尿外科杂志,2005,26(8):525-528. 被引量:3
  • 7Lieaching T, Kwok H. Hill NS. Acute applications of noninvasive positive pressure ventilation. Chest, 2003,124 : 699-713.

二级参考文献5

  • 1Emery VC. Prophylaxis for CMV should not now replace pre-emptive therapy in solid organ transplantation. Rev Med Virol,2001,11:83-86.
  • 2Rollag H, Sagedal S, Kristiansen KI,et al. Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients. Clin Microbiol Infect, 2002,8 : 431 -434.
  • 3Honda J, Yonemitsu J, Kitajima H, et al. Clinical utility of capillary polymerase chain reaction for diagnosis of Cytomegalovirus pneumonia. Scand J Infect Dis,2001,33:702-705.
  • 4Grundy JE. Virologic and pathogenetic aspects of cytomegalovirus infection. Rev Infect Dis, 1990,2 ( suppl ) : 711-719.
  • 5Tanaka K, Noda S. Role of nitric oxide in murine cytomegalovirus(MCMV) infection. Histol Histopatho1,2001 , 16:937-944.

共引文献480

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部